Obinutuzumab for treating serologically active extra-renal lupus [ID6670]

  • In development
  • GID-TA11886
  • Expected publication date: 

Documents

Documents created during the development process.

Committee meetings

  • Committee meeting

Invitation to participate

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Topic selection